SSG
IART icon

Summit Securities Group’s Integra LifeSciences IART Stock Holding History

Summit Securities Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75K Buy
+4,176
New +$58.4K 0.01% 491
2025
Q3 		– Sell
-5,361
Closed -$65.8K – 1183
2025
Q2 		$65.8K Buy
+5,361
New +$77.8K 0.01% 445
2013
Q4 		– Sell
-734
Closed -$12K – 558
2013
Q3 		$12K Buy
+734
New +$11.8K ﹤0.01% 253

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Summit Securities Group's IART Position: Q2 2026 in Review

Summit Securities Group opened a new position in Integra LifeSciences (IART) in Q2 2026: 4,176 shares worth $75K. The stake represents 0.01% of the portfolio and ranks #491 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in IART as recently as Q2 2025.

Summit Securities Group first reported a position in IART in Q3 2013 and has held it in 3 quarters since. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Summit Securities Group held 4,176 shares of Integra LifeSciences worth $75K as of Q2 2026.
  • Integra LifeSciences was a new Summit Securities Group position in Q2 2026.
  • Integra LifeSciences made up 0.01% of Summit Securities Group's portfolio in Q2 2026, its #491 holding.
  • Summit Securities Group first reported a position in Integra LifeSciences in Q3 2013 and has held it in 3 quarters since.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.